Upregulation of the elongation factor-α gene by p53 in association with death of an erythroleukemic cell line

Blood

Volumn 90, Issue 4, 1997, Pages 1373-1378

  Kato, Mitsuo V ^a   Sato, Hiromi ^b   Nagayoshi, Mariko ^b   Ikawa, Yoji ^b  

^a RIKEN TSUKUBA INSTITUTE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; PHOSPHOPROTEIN; PROTEIN TYROSINE KINASE; TRANSACTIVATOR PROTEIN; VASCULOTROPIN;

ARTICLE; BINDING SITE; CELL MIGRATION; CELL POLARITY; CELL SHAPE; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN PHOSPHORYLATION;

EID: 0030843268     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.4.1373     Document Type: Article

References (40)

1. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855, 1994
2. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B: Identification of p53 as a sequence-specific DNA-binding protein. Science 252:1708, 1991
3. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B: Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256:827, 1992
4. El-Dairy WS, Tokino T, Veculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75:817, 1993
5. Wu X, Bayle JH, Olson D, Levine AJ: The p53-mdm-2 auto-regulatory feedback loop. Genes Dev 7:1126, 1993
6. Weintraub H, Haushka S, Tapscott S: The MCK enhancer contains a p53 responsive element. Proc Nalt Acad Sci USA 88:4570, 1991
7. Zambetti GP, Bargonetti J, Walker K, Prives C, Levine AJ: Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev 6:1143, 1992
8. Kastan MB, Zhan Q, El-Dairy WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ Jr: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587, 1992
9. Okamoto K, Beach D: Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J 13:4816, 1994
10. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293, 1995
11. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, Kley N: Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646, 1995
12. Harper JW, Adami GR, Wei N, Keyomarsi K, Elleldge S: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805, 1993
13. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366:701, 1993
14. Gu Y, Turck CW and Morgan DO: Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366:707, 1993
15. Waga S, Hannon GJ, Beach D, Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574, 1994
16. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211:90, 1994
17. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M: Nature 352:345, 1991
18. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847, 1993
19. Clarke AR, Purdie CA, Harrfson DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849, 1993
20. Pan H, Griep AE: Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implications for tumor suppressor gene function in development. Genes Dev 8:1285, 1994
21. Morgenbesser SD, Williams BO, Jacks T, DePinho RA: p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371:72, 1994
22. Howes KA, Ransom N, Papermaster DS, Lasudry JGH, Albert DM, Windle JJ: Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev 8:1300, 1994
23. Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Dyke TV: p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78:703, 1994
24. White E: p53, guardian of Rb. Nature 371:21, 1994
25. Oltvai ZN, Milliman CL, Korsmeiyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609, 1993
26. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Onogene 9:1799, 1994
27. Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth AB, Zhang WW, Kruzel E, Radinsky R: Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 15:3032, 1995
28. Kato MV, Sato H, Ishizaki K, Anzai H, Nagayoshi M, Ikawa Y: No significant changes in the expression of the fas, fasl, bcl-2 and bax genes in apoptosis of an erythroleukemic cell line by p53. Int J Oncol 9:269, 1996
29. Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967, 1992
30. Kaziro Y: The role of guanosine 5′-triphosphate in polypeptide chain elongation. Biochim Biophys Acta 505:95, 1978
31. Shiina N, Gotoh Y, Kubomura N, Iwamatsu A, Nishida E: Microtubule severing by elongation factor 1 alpha. Science 266:282, 1994
32. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
33. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463, 1977
34. Pearson WR, Lipman DJ: Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 85:2444, 1988
35. Piperno G, LeDizet M, Chang XJ: Microtubules containing acetylated alpha-tubulin in mammalian cells in culture. J Cell Biol 104:289, 1987
36. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B: Definition of a consensus binding site for p53. Nat Genet 1:45, 1992
37. Morimoto H, Bonavida B: Diphtheria toxin-and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha. J Immunol 149:2089, 1992
38. Murphy M, Hinman A, Levine AJ: Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev 10:2971, 1996
39. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ: A p53-dependent mouse spindle checkpoint. Science 267:1353, 1995
40. Wang Y, Prives C: Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature 376:88, 1995